Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation

Autor: Weinacht, Katja G., Charbonnier, Louis-Marie, Alroqi, Fayhan, Plant, Ashley, Qiao, Qi, Wu, Hao, Ma, Clement, Torgerson, Troy R., Rosenzweig, Sergio D., Fleisher, Thomas A., Notarangelo, Luigi D., Hanson, Imelda C., Forbes, Lisa R., Chatila, Talal A.
Zdroj: In The Journal of Allergy and Clinical Immunology May 2017 139(5):1629-1640
Databáze: ScienceDirect
Externí odkaz: